{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:06:25Z","timestamp":1761588385546,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109034","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T19:57:00Z","timestamp":1657569420000},"page":"109034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN\/PDGFR-\u03b2"],"prefix":"10.1016","volume":"110","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Min","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Di","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Yin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Guo","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Lu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2022.109034_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2022.109034_b0010","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.7150\/thno.32935","article-title":"SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.intimp.2022.109034_b0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24784","article-title":"Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells","volume":"55","author":"Knight","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109034_b0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"32","key":"10.1016\/j.intimp.2022.109034_b0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2022.109034_b0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.4104","article-title":"The myofibroblast matrix: implications for tissue repair and fibrosis","volume":"229","author":"Klingberg","year":"2013","journal-title":"J. Pathol."},{"issue":"25","key":"10.1016\/j.intimp.2022.109034_b0035","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.7150\/thno.38913","article-title":"The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis","volume":"9","author":"Kumar","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2022.109034_b0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7150\/thno.21168","article-title":"Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development","volume":"8","author":"Sung","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2022.109034_b0045","doi-asserted-by":"crossref","unstructured":"Popper H, Uenfriend S. Hepatic fibrosis. Correlation of biochemical and morphologic investigations. The American journal of medicine 1970;49:707-21.","DOI":"10.1016\/S0002-9343(70)80135-8"},{"issue":"2","key":"10.1016\/j.intimp.2022.109034_b0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2022.109034_b0055","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2014.07.017","article-title":"Circulating microRNAs as markers of liver inflammation, fibrosis and cancer","volume":"61","author":"Roderburg","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2022.109034_b0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2022.109034_b0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.trsl.2015.04.014","article-title":"High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis","volume":"166","author":"Leti","year":"2015","journal-title":"Transl. Res. : J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109034_b0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.29153","article-title":"Hepatic mitochondrial DNA\/Toll-like receptor 9\/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice","volume":"66","author":"He","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109034_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00011-016-1020-4","article-title":"miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1\/Notch1 signal pathway","volume":"66","author":"Yang","year":"2017","journal-title":"Inflam. Res.: Off. J. Eur. Histamine Res. Soc. [et al]"},{"issue":"27","key":"10.1016\/j.intimp.2022.109034_b0080","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.2174\/1381612826666201023143542","article-title":"Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update","volume":"27","author":"Zhu","year":"2021","journal-title":"Curr. Pharmaceut. Design"},{"key":"10.1016\/j.intimp.2022.109034_b0085","doi-asserted-by":"crossref","unstructured":"Shi W, Gerster K, Alajez NM, Tsang J, Waldron L, Pintilie M, et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer research 2011;71:2926-37.","DOI":"10.1158\/0008-5472.CAN-10-3369"},{"issue":"1-2","key":"10.1016\/j.intimp.2022.109034_b0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000452540","article-title":"Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma","volume":"40","author":"Cui","year":"2016","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"25","key":"10.1016\/j.intimp.2022.109034_b0095","doi-asserted-by":"crossref","first-page":"21046","DOI":"10.18632\/oncotarget.4124","article-title":"MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4","volume":"6","author":"Xia","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.intimp.2022.109034_b0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.prp.2018.09.008","article-title":"MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4","volume":"214","author":"Hu","year":"2018","journal-title":"Pathol., Res. Pract."},{"issue":"10","key":"10.1016\/j.intimp.2022.109034_b0105","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00535-016-1178-0","article-title":"A micro-RNA expression signature for human NAFLD progression","volume":"51","author":"Guo","year":"2016","journal-title":"J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109034_b0110","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/infdis\/jix140","article-title":"Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients","volume":"215","author":"van der Ree","year":"2017","journal-title":"J. Infect. Diseases"},{"issue":"5","key":"10.1016\/j.intimp.2022.109034_b0115","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.24281","article-title":"The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2\/gp91(phox) mediate hepatic fibrosis in mice","volume":"53","author":"Paik","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2022.109034_b0120","doi-asserted-by":"crossref","first-page":"101479","DOI":"10.1016\/j.redox.2020.101479","article-title":"Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS production","volume":"32","author":"Wang","year":"2020","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109034_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1032-9","article-title":"Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2022.109034_b0130","doi-asserted-by":"crossref","first-page":"105838","DOI":"10.1016\/j.intimp.2019.105838","article-title":"Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms","volume":"76","author":"Chen","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.intimp.2022.109034_b0135","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1042\/CS20190599","article-title":"RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress","volume":"133","author":"Wang","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.intimp.2022.109034_b0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxlet.2017.04.008","article-title":"Hesperetin derivative-14 alleviates inflammation by activating PPAR-gamma in mice with CCl4-induced acute liver injury and LPS-treated RAW264.7 cells","volume":"274","author":"Chen","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2022.109034_b0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annual review of pathology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109034_b0150","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/gast.2002.33367","article-title":"Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C","volume":"122","author":"Arthur","year":"2002","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.intimp.2022.109034_b0155","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.7150\/thno.42423","article-title":"Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p\/FBXW7 axis","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2022.109034_b0160","first-page":"501","article-title":"A PDGFRbeta-based score predicts significant liver fibrosis in patients with chronic alcohol abuse","volume":"43","author":"Lambrecht","year":"2019","journal-title":"NAFLD and viral liver disease. EBioMedicine"},{"key":"10.1016\/j.intimp.2022.109034_b0165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.omtn.2019.02.014","article-title":"MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta","volume":"16","author":"Yang","year":"2019","journal-title":"Mol. Therapy Nucl. Acids"},{"issue":"2","key":"10.1016\/j.intimp.2022.109034_b0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11095-014-1497-x","article-title":"Delivery and targeting of miRNAs for treating liver fibrosis","volume":"32","author":"Kumar","year":"2015","journal-title":"Pharmaceut. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109034_b0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","article-title":"Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights","volume":"51","author":"Greuter","year":"2016","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.intimp.2022.109034_b0180","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/thno.22237","article-title":"Ligand Activation of PPARgamma by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1alpha","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.intimp.2022.109034_b0185","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.intimp.2022.109034_b0190","doi-asserted-by":"crossref","unstructured":"M. Kitano, P.M. Bloomston, Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis, J. Clin. Med. 2016, 5.","DOI":"10.3390\/jcm5030038"},{"key":"10.1016\/j.intimp.2022.109034_b0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijbiomac.2022.05.041","article-title":"ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p\/BTG1 pathway","volume":"211","author":"Luan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2022.109034_b0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2017.01.005","article-title":"The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis","volume":"317","author":"Cheng","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109034_b0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tox.2016.11.004","article-title":"Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN\/AKT pathway","volume":"381","author":"Li","year":"2017","journal-title":"Toxicology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:59:32Z","timestamp":1761587972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":41,"alternative-id":["S1567576922005185"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109034","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN\/PDGFR-\u03b2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109034"}}